Pharmacology and the Nursing Process 9th Edition Test Ban
mx mx mx mx mx mx mx mx
k
Test Bank for
mx mx
PharmacologyandtheNursing Process9 thEd m
x m
x m
x m
x m
x mx
itionAuthors: Linda Lilley, Shelly Collins, Julie Snyder
mx mx mx mx mx mx
PART 1: PHARMACOLOGY BASICS
mx mx mx
Chapter 1 - The Nursing Process and Drug Therapy _________________________________ 3
mx mx mx mx mx mx m x mx
Chapter 2 - Pharmacologic Principles ____________________________________________ 7
mx mx m x mx
Chapter 3 - Lifespan Considerations _____________________________________________ 13
mx mx mx mx
Chapter 4 - Cultural Legal and Ethical Considerations _______________________________ 19
mx mx mx mx mx m x mx
Chapter 5 - Medication Errors Preventing and Responding ___________________________ 25
mx mx mx mx mx m x mx
Chapter 6 - Patient Education and Drug Therapy ___________________________________ 29
mx mx mx mx mx m x mx
Chapter 7 - Over-the-Counter Drugs and Herbal and Dietary Supplements ________________ 34
mx mx mx mx mx mx mx mx mx
Chapter 8 - Gene Therapy and Pharmacogenomics__________________________________ 38
mx mx mx mx m x mx
Chapter 9 - Photo Atlas of Drug Administration ____________________________________ 42
mx mx mx mx jc m x mx
PART 2: DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM
mx mx mx mx mx mx mx
Chapter 10 - Analgesic Drugs __________________________________________________ 50
mx mx mx mx
Chapter 11 - General and Local Anesthetics _______________________________________ 57
mx mx mx mx m x mx
Chapter 12 - Central Nervous System Depressants and Muscle Relaxants 61 Chapter 13 -
mx mx mx mx mx mx mx mx mx mx mx mx mx
Central Nervous System Stimulants and Related Drugs_____________________________ 66
m x mx mx mx m x mx
Chapter 14 - Antiepileptic Drugs ________________________________________________ 70
mx mx mx mx
Chapter 15 - Anti-Parkinson Drugs ______________________________________________ 75
mx mx mx mx
Chapter 16 - Psychotherapeutic Drugs ____________________________________________ 80
mx mx mx mx
Chapter 17 - Substance Use Disorder ____________________________________________ 87
mx mx mx m x mx
PART 3: DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM
mx mx mx mx mx mx mx
Chapter 18 - Adrenergic Drugs _________________________________________________ 92
mx mx mx mx
Chapter 19 - Adrenergic-Blocking Drugs _________________________________________ 97
mx mx m x mx
Chapter 1 -
mx mx 1
The Nursing Process and Drug Therapy
mx mx mx mx mx mx
, Pharmacology and the Nursing Process 9th Edition Test Ban
mx mx mx mx mx mx mx mx
k Chapter 20 - Cholinergic Drugs _________________________________________________
mx mx mx mx 102
Chapter 21 - Cholinergic-Blocking Drugs _________________________________________ 107
mx mx m x mx
PART 4: DRUGS AFFECTING THE CARDIOVASCULAR AND RENAL SYSTEMS
mx mx mx mx mx jc mx mx
Chapter 22 - Antihypertensive Drugs_____________________________________________ 112
mx mx m x mx
Chapter 23 - Antianginal Drugs _________________________________________________ 118
mx mx mx mx
Chapter 24 - Heart Failure Drugs ________________________________________________ 124
mx mx mx m x mx
Chapter 25 - Antidysrhythmic Drugs _____________________________________________ 129
mx mx mx mx
Chapter 26 - Coagulation Modifier Drugs _________________________________________ 134
mx mx mx m x mx
Chapter 27 - Antilipemic Drugs _________________________________________________ 140
mx mx mx mx
Chapter 28 - Diuretic Drugs ____________________________________________________ 145
mx mx mx mx
Chapter 29 - Fluids and Electrolytes _____________________________________________ 151
mx mx mx m x mx
PART 5: DRUGS AFFECTING THE ENDOCRINE AND REPRODUCTIVE SYSTEMS
mx mx mx mx mx mx mx mx
Chapter 30 - Pituitary Drugs____________________________________________________ 157
mx mx mx mx
Chapter 31 - Thyroid and Antithyroid Drugs ______________________________________ 161
mx mx mx mx m x mx
Chapter 32 - Antidiabetic Drugs_________________________________________________ 166
mx mx mx mx
Chapter 33 - Adrenal Drugs ____________________________________________________ 174
mx mx mx mx
Chapter 34 - Women’s Health Drugs _____________________________________________ 178
mx mx mx m x mx
Chapter 35 - Men’s Health Drugs _______________________________________________ 185
mx mx mx m x mx
PART 6: DRUGS AFFECTING THE RESPIRATORY SYSTEM
mx mx mx mx mx mx
Chapter 36 - Antihistamines Decongestants Antitussives and Expectorants _________________ 189
mx mx mx mx mx mx mx
Chapter 37 - Respiratory Drugs _________________________________________________ 194
mx mx mx mx
PART 7: ANTIINFECTIVE AND ANTIINFLAMMATORY DRUGS
mx mx mx mx mx
Chapter 38 - Antibiotics Part 1 __________________________________________________ 199
mx mx mx mx mx
Chapter 39 - Antibiotics Part 2 __________________________________________________ 206
mx mx mx mx mx
Chapter 40 - Antiviral Drugs ___________________________________________________ 211
mx mx mx mx
Chapter 41 - Antitubercular Drugs _______________________________________________ 216
mx mx mx mx
Chapter 42 - Antifungal Drugs __________________________________________________ 221
mx mx mx mx
Chapter 43 - Antimalarial Antiprotozoal and
m
x mx mx mx mx m x Anthelmintic Drugs ______________________ 226
mx
Chapter 44 - Anti-inflammatory and Antigout Drugs ________________________________ 231
mx mx mx mx m x mx
PART 8: CHEMOTHERAPEUTIC DRUGS AND BIOLOGIC
AND IMMUNE MODIFIERS
mx mx
Chapter 45 - Antineoplastic Drugs Part 1 Cancer Overview and Cell Cycle ________________ 236
mx mx mx mx mx mx mx mx mx mx mx
Chapter 46 - Antineoplastic Drugs Part 2 Cell Cycle Nonspecific and Misc. Drugs _________ 242
m
x mx mx mx mx jc mx mx mx mx m x mx
Chapter 1 -
mx mx 2
The Nursing Process and Drug Therapy
mx mx mx mx mx mx
, Pharmacology and the Nursing Process 9th Edition Test Ban
mx mx mx mx mx mx mx mx
k Chapter 47 - Biologic Response–Modifying and
m
x mx mx mx mx m x Antirheumatic Drugs__________________ 247 mx
Chapter 48 - Immunosuppressant Drugs __________________________________________ 252
mx mx m x mx
Chapter 49 - Immunizing Drugs_________________________________________________ 257
mx mx mx mx
PART 9: DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM AND NUTRITION
mx mx mx mx mx mx mx mx
Chapter 50 - Acid-Controlling Drugs ____________________________________________ 262
mx mx mx mx
Chapter 51 - Bowel Disorder Drugs ______________________________________________ 268
mx mx mx m x mx
Chapter 52 - Antiemetic and Antinausea Drugs ____________________________________ 275
mx mx mx mx m x mx
Chapter 53 - Vitamins and Minerals _____________________________________________ 280
mx mx mx m x mx
Chapter 54 - Anemia Drugs ____________________________________________________ 286
mx mx mx mx
Chapter 55 - Nutritional Supplements ____________________________________________ 292
mx mx m x mx
PART 10: DERMATOLOGIC, OPHTHALMIC, AND OTIC DRUGS
mx mx mx mx mx mx
Chapter 56 - Drugs ___________________________________________________________ 296
mx mx mx
Chapter 57 - Ophthalmic Drugs _________________________________________________ 302
mx mx mx mx
Chapter 58 - Otic Drugs _______________________________________________________ 307
mx mx mx mx
Chapter 01: The Nursing Process and Drug Therapy Lilley:
mx mx mx mx mx mx mx mx
Pharmacology and the Nursing Process, 9th Edition
mx mx mx mx jc mx mx
MULTIPLE CHOICE mx
1. The nurse is developing a human needs statement for a patient who has a new diagnosis of he
mx mx mx mx mx jc mx mx mx mx jc mx mx mx mx jc mx
art failure. Identification of human needs statements occur with which of these activities
mx mx mx jc mx jc mx mx mx mx jc mx mx
?
a. Collection of patient data mx mx mx
b. Administering interventions mx
c. Deciding on patient outcomes jc jc mx
d. Documenting the patient’s behavior mx mx mx
ANS:A
Identification of human needs occurs with the collection of patient data.
mx mx mx mx jc mx mx mx mx mx
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Proces
mx mx mx jc mx mx jc
s: Human Needs Statement
mx mx jc
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
mx mx mx mx mx mx mx mx mx
2. Thepatient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nursewas b
jc mx jc mx mx mx mx mx mx mx mx mx mx
u sy and gave the medication 2 hours after the scheduled dose was due. What type of pr
mx mx mx mx mx mx mx mx mx mx mx mx mx mx mx mx mx
obl em does this represent?
mx mx mx mx
a. “Right time” mx
b. “Right dose” mx
c. “Right route” mx
d. “Right medication” mx
ANS:A
“Right time” is correct because the medication was given more than 30 minutes after the
mx mx mx mx mx mx mx mx mx mx mx mx mx mx
Chapter 1 -
mx mx 3
The Nursing Process and Drug Therapy
mx mx mx mx mx mx
, Pharmacology and the Nursing Process 9th Edition Test Ban
mx mx mx mx mx mx mx mx
k scheduled dose was due. “Dose” is incorrect because the dose is not related to
jc the time the m
mx mx mx mx mx mx mx mx mx mx jc mx mx mx mx mx
e dication administration is scheduled. “Route” is incorrect because the route is not affecte
mx mx mx mx mx mx mx jc mx mx mx jc mx
d. “ Medication” is incorrect because the medication ordered will not change.
mx mx mx mx jc mx mx mx mx mx mx
DIF: Cognitive Level: Applying (Application) TOP:
mx mx mx jc mx
Nursing Process: Implementation jc mx
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
mx mx mx mx mx mx mx mx mx mx
3. The nurse has been monitoring the patient’s progress on a new drug regimen since the first d
mx mx jc mx jc mx mx mx mx mx mx mx mx mx mx jc
o se and documenting the patient’s therapeutic response to the medication. Which phase of
mx mx mx mx mx mx mx mx mx mx mx mx mx mx
the nursing process do these actions illustrate?
mx mx mx mx mx mx
a. Human needs statement mx mx
b. Planning
c. Implementation
d. Evaluation
ANS:D
Monitoring the patient’s progress, including the patient’s response to the medication, is pa
mx mx mx mx mx mx mx mx mx mx mx mx
rt of the evaluation phase. Planning, implementation, and human needs statement are not illu
mx jc mx mx mx mx mx jc mx mx mx mx mx
str ated by this example.
mx mx mx mx
DIF: Cognitive Level: Understanding (Comprehension)
mx mx mx jc
TOP:Nursing Process: jc
Evaluation
MSC: NCLEX :Safe and Effective Care Environment: Management of Care
mx jc mx mx mx mx mx mx mx
4. The nurse is assigned to a patient who is newly diagnosed with type 1 diabetes mellitus. W
mx jc mx jc mx mx mx mx mx mx mx mx jc mx mx mx
hich statement best illustrates an outcome criterion for this patient?
mx mx jc mx mx mx mx jc mx mx
a. The patient will follow instructions.
mx mx mx mx
b. The patient will not experience complications.
mx mx mx mx mx
c. The patient will adhere to the new insulin treatment regimen.
mx jc mx mx mx mx mx mx mx
d. The patient will demonstrate correct blood glucose testing technique.
mx mx mx mx mx jc mx mx
ANS: D mx
“Demonstrating correct blood glucose testing technique” is a specific and measurable outc
mx mx mx mx mx mx mx mx jc mx mx
o me criterion. “Following instructions” and “not experiencing complications” arenot speci
mx mx mx mx mx mx mx mx mx mx
fic criteria. “Adhering to new regimen” would be difficult to measure.
mx mx mx mx mx mx mx mx jc mx
DIF: Cognitive Level: Applying (Application)
mx mx mx mx
TOP:Nursing Process: jc
Planning
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
mx mx mx jc mx mx mx mx mx
5. Which activity best reflects the implementation phase of the nursing process for the patient w
mx mx jc mx mx mx mx mx mx jc mx mx mx mx mx
ho is newly diagnosed with hypertension?
mx mx mx mx mx
a. Providing education on keeping a journal of blood pressure readingsmx jc mx mx mx mx mx mx mx
b. Setting goals and outcome criteria with the patient’s input
mx mx mx mx jc mx mx mx
c. Recording a drug history regarding over-the-counter medications used at home
jc mx mx mx mx mx mx jc mx
d. Formulating human needs statements regarding insufficient knowledge related to t mx mx mx mx mx mx mx jc mx
he new treatment regimen
mx mx mx jc
ANS: A mx
Education is an intervention that occurs during the implementation phase. Setting goals and
mx mx mx mx mx mx mx mx jc mx mx mx
outcomes reflects the planning phase. Recording a drug history reflects the assessment phase
mx jc jc mx mx mx mx mx jc mx mx mx jc
. Formulating human needs statements reflects analysis of data as part of planning.
mx mx mx mx mx mx mx mx mx mx mx mx
Chapter 1 -
mx mx 4
The Nursing Process and Drug Therapy
mx mx mx mx mx mx
mx mx mx mx mx mx mx mx
k
Test Bank for
mx mx
PharmacologyandtheNursing Process9 thEd m
x m
x m
x m
x m
x mx
itionAuthors: Linda Lilley, Shelly Collins, Julie Snyder
mx mx mx mx mx mx
PART 1: PHARMACOLOGY BASICS
mx mx mx
Chapter 1 - The Nursing Process and Drug Therapy _________________________________ 3
mx mx mx mx mx mx m x mx
Chapter 2 - Pharmacologic Principles ____________________________________________ 7
mx mx m x mx
Chapter 3 - Lifespan Considerations _____________________________________________ 13
mx mx mx mx
Chapter 4 - Cultural Legal and Ethical Considerations _______________________________ 19
mx mx mx mx mx m x mx
Chapter 5 - Medication Errors Preventing and Responding ___________________________ 25
mx mx mx mx mx m x mx
Chapter 6 - Patient Education and Drug Therapy ___________________________________ 29
mx mx mx mx mx m x mx
Chapter 7 - Over-the-Counter Drugs and Herbal and Dietary Supplements ________________ 34
mx mx mx mx mx mx mx mx mx
Chapter 8 - Gene Therapy and Pharmacogenomics__________________________________ 38
mx mx mx mx m x mx
Chapter 9 - Photo Atlas of Drug Administration ____________________________________ 42
mx mx mx mx jc m x mx
PART 2: DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM
mx mx mx mx mx mx mx
Chapter 10 - Analgesic Drugs __________________________________________________ 50
mx mx mx mx
Chapter 11 - General and Local Anesthetics _______________________________________ 57
mx mx mx mx m x mx
Chapter 12 - Central Nervous System Depressants and Muscle Relaxants 61 Chapter 13 -
mx mx mx mx mx mx mx mx mx mx mx mx mx
Central Nervous System Stimulants and Related Drugs_____________________________ 66
m x mx mx mx m x mx
Chapter 14 - Antiepileptic Drugs ________________________________________________ 70
mx mx mx mx
Chapter 15 - Anti-Parkinson Drugs ______________________________________________ 75
mx mx mx mx
Chapter 16 - Psychotherapeutic Drugs ____________________________________________ 80
mx mx mx mx
Chapter 17 - Substance Use Disorder ____________________________________________ 87
mx mx mx m x mx
PART 3: DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM
mx mx mx mx mx mx mx
Chapter 18 - Adrenergic Drugs _________________________________________________ 92
mx mx mx mx
Chapter 19 - Adrenergic-Blocking Drugs _________________________________________ 97
mx mx m x mx
Chapter 1 -
mx mx 1
The Nursing Process and Drug Therapy
mx mx mx mx mx mx
, Pharmacology and the Nursing Process 9th Edition Test Ban
mx mx mx mx mx mx mx mx
k Chapter 20 - Cholinergic Drugs _________________________________________________
mx mx mx mx 102
Chapter 21 - Cholinergic-Blocking Drugs _________________________________________ 107
mx mx m x mx
PART 4: DRUGS AFFECTING THE CARDIOVASCULAR AND RENAL SYSTEMS
mx mx mx mx mx jc mx mx
Chapter 22 - Antihypertensive Drugs_____________________________________________ 112
mx mx m x mx
Chapter 23 - Antianginal Drugs _________________________________________________ 118
mx mx mx mx
Chapter 24 - Heart Failure Drugs ________________________________________________ 124
mx mx mx m x mx
Chapter 25 - Antidysrhythmic Drugs _____________________________________________ 129
mx mx mx mx
Chapter 26 - Coagulation Modifier Drugs _________________________________________ 134
mx mx mx m x mx
Chapter 27 - Antilipemic Drugs _________________________________________________ 140
mx mx mx mx
Chapter 28 - Diuretic Drugs ____________________________________________________ 145
mx mx mx mx
Chapter 29 - Fluids and Electrolytes _____________________________________________ 151
mx mx mx m x mx
PART 5: DRUGS AFFECTING THE ENDOCRINE AND REPRODUCTIVE SYSTEMS
mx mx mx mx mx mx mx mx
Chapter 30 - Pituitary Drugs____________________________________________________ 157
mx mx mx mx
Chapter 31 - Thyroid and Antithyroid Drugs ______________________________________ 161
mx mx mx mx m x mx
Chapter 32 - Antidiabetic Drugs_________________________________________________ 166
mx mx mx mx
Chapter 33 - Adrenal Drugs ____________________________________________________ 174
mx mx mx mx
Chapter 34 - Women’s Health Drugs _____________________________________________ 178
mx mx mx m x mx
Chapter 35 - Men’s Health Drugs _______________________________________________ 185
mx mx mx m x mx
PART 6: DRUGS AFFECTING THE RESPIRATORY SYSTEM
mx mx mx mx mx mx
Chapter 36 - Antihistamines Decongestants Antitussives and Expectorants _________________ 189
mx mx mx mx mx mx mx
Chapter 37 - Respiratory Drugs _________________________________________________ 194
mx mx mx mx
PART 7: ANTIINFECTIVE AND ANTIINFLAMMATORY DRUGS
mx mx mx mx mx
Chapter 38 - Antibiotics Part 1 __________________________________________________ 199
mx mx mx mx mx
Chapter 39 - Antibiotics Part 2 __________________________________________________ 206
mx mx mx mx mx
Chapter 40 - Antiviral Drugs ___________________________________________________ 211
mx mx mx mx
Chapter 41 - Antitubercular Drugs _______________________________________________ 216
mx mx mx mx
Chapter 42 - Antifungal Drugs __________________________________________________ 221
mx mx mx mx
Chapter 43 - Antimalarial Antiprotozoal and
m
x mx mx mx mx m x Anthelmintic Drugs ______________________ 226
mx
Chapter 44 - Anti-inflammatory and Antigout Drugs ________________________________ 231
mx mx mx mx m x mx
PART 8: CHEMOTHERAPEUTIC DRUGS AND BIOLOGIC
AND IMMUNE MODIFIERS
mx mx
Chapter 45 - Antineoplastic Drugs Part 1 Cancer Overview and Cell Cycle ________________ 236
mx mx mx mx mx mx mx mx mx mx mx
Chapter 46 - Antineoplastic Drugs Part 2 Cell Cycle Nonspecific and Misc. Drugs _________ 242
m
x mx mx mx mx jc mx mx mx mx m x mx
Chapter 1 -
mx mx 2
The Nursing Process and Drug Therapy
mx mx mx mx mx mx
, Pharmacology and the Nursing Process 9th Edition Test Ban
mx mx mx mx mx mx mx mx
k Chapter 47 - Biologic Response–Modifying and
m
x mx mx mx mx m x Antirheumatic Drugs__________________ 247 mx
Chapter 48 - Immunosuppressant Drugs __________________________________________ 252
mx mx m x mx
Chapter 49 - Immunizing Drugs_________________________________________________ 257
mx mx mx mx
PART 9: DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM AND NUTRITION
mx mx mx mx mx mx mx mx
Chapter 50 - Acid-Controlling Drugs ____________________________________________ 262
mx mx mx mx
Chapter 51 - Bowel Disorder Drugs ______________________________________________ 268
mx mx mx m x mx
Chapter 52 - Antiemetic and Antinausea Drugs ____________________________________ 275
mx mx mx mx m x mx
Chapter 53 - Vitamins and Minerals _____________________________________________ 280
mx mx mx m x mx
Chapter 54 - Anemia Drugs ____________________________________________________ 286
mx mx mx mx
Chapter 55 - Nutritional Supplements ____________________________________________ 292
mx mx m x mx
PART 10: DERMATOLOGIC, OPHTHALMIC, AND OTIC DRUGS
mx mx mx mx mx mx
Chapter 56 - Drugs ___________________________________________________________ 296
mx mx mx
Chapter 57 - Ophthalmic Drugs _________________________________________________ 302
mx mx mx mx
Chapter 58 - Otic Drugs _______________________________________________________ 307
mx mx mx mx
Chapter 01: The Nursing Process and Drug Therapy Lilley:
mx mx mx mx mx mx mx mx
Pharmacology and the Nursing Process, 9th Edition
mx mx mx mx jc mx mx
MULTIPLE CHOICE mx
1. The nurse is developing a human needs statement for a patient who has a new diagnosis of he
mx mx mx mx mx jc mx mx mx mx jc mx mx mx mx jc mx
art failure. Identification of human needs statements occur with which of these activities
mx mx mx jc mx jc mx mx mx mx jc mx mx
?
a. Collection of patient data mx mx mx
b. Administering interventions mx
c. Deciding on patient outcomes jc jc mx
d. Documenting the patient’s behavior mx mx mx
ANS:A
Identification of human needs occurs with the collection of patient data.
mx mx mx mx jc mx mx mx mx mx
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Proces
mx mx mx jc mx mx jc
s: Human Needs Statement
mx mx jc
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
mx mx mx mx mx mx mx mx mx
2. Thepatient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nursewas b
jc mx jc mx mx mx mx mx mx mx mx mx mx
u sy and gave the medication 2 hours after the scheduled dose was due. What type of pr
mx mx mx mx mx mx mx mx mx mx mx mx mx mx mx mx mx
obl em does this represent?
mx mx mx mx
a. “Right time” mx
b. “Right dose” mx
c. “Right route” mx
d. “Right medication” mx
ANS:A
“Right time” is correct because the medication was given more than 30 minutes after the
mx mx mx mx mx mx mx mx mx mx mx mx mx mx
Chapter 1 -
mx mx 3
The Nursing Process and Drug Therapy
mx mx mx mx mx mx
, Pharmacology and the Nursing Process 9th Edition Test Ban
mx mx mx mx mx mx mx mx
k scheduled dose was due. “Dose” is incorrect because the dose is not related to
jc the time the m
mx mx mx mx mx mx mx mx mx mx jc mx mx mx mx mx
e dication administration is scheduled. “Route” is incorrect because the route is not affecte
mx mx mx mx mx mx mx jc mx mx mx jc mx
d. “ Medication” is incorrect because the medication ordered will not change.
mx mx mx mx jc mx mx mx mx mx mx
DIF: Cognitive Level: Applying (Application) TOP:
mx mx mx jc mx
Nursing Process: Implementation jc mx
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
mx mx mx mx mx mx mx mx mx mx
3. The nurse has been monitoring the patient’s progress on a new drug regimen since the first d
mx mx jc mx jc mx mx mx mx mx mx mx mx mx mx jc
o se and documenting the patient’s therapeutic response to the medication. Which phase of
mx mx mx mx mx mx mx mx mx mx mx mx mx mx
the nursing process do these actions illustrate?
mx mx mx mx mx mx
a. Human needs statement mx mx
b. Planning
c. Implementation
d. Evaluation
ANS:D
Monitoring the patient’s progress, including the patient’s response to the medication, is pa
mx mx mx mx mx mx mx mx mx mx mx mx
rt of the evaluation phase. Planning, implementation, and human needs statement are not illu
mx jc mx mx mx mx mx jc mx mx mx mx mx
str ated by this example.
mx mx mx mx
DIF: Cognitive Level: Understanding (Comprehension)
mx mx mx jc
TOP:Nursing Process: jc
Evaluation
MSC: NCLEX :Safe and Effective Care Environment: Management of Care
mx jc mx mx mx mx mx mx mx
4. The nurse is assigned to a patient who is newly diagnosed with type 1 diabetes mellitus. W
mx jc mx jc mx mx mx mx mx mx mx mx jc mx mx mx
hich statement best illustrates an outcome criterion for this patient?
mx mx jc mx mx mx mx jc mx mx
a. The patient will follow instructions.
mx mx mx mx
b. The patient will not experience complications.
mx mx mx mx mx
c. The patient will adhere to the new insulin treatment regimen.
mx jc mx mx mx mx mx mx mx
d. The patient will demonstrate correct blood glucose testing technique.
mx mx mx mx mx jc mx mx
ANS: D mx
“Demonstrating correct blood glucose testing technique” is a specific and measurable outc
mx mx mx mx mx mx mx mx jc mx mx
o me criterion. “Following instructions” and “not experiencing complications” arenot speci
mx mx mx mx mx mx mx mx mx mx
fic criteria. “Adhering to new regimen” would be difficult to measure.
mx mx mx mx mx mx mx mx jc mx
DIF: Cognitive Level: Applying (Application)
mx mx mx mx
TOP:Nursing Process: jc
Planning
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
mx mx mx jc mx mx mx mx mx
5. Which activity best reflects the implementation phase of the nursing process for the patient w
mx mx jc mx mx mx mx mx mx jc mx mx mx mx mx
ho is newly diagnosed with hypertension?
mx mx mx mx mx
a. Providing education on keeping a journal of blood pressure readingsmx jc mx mx mx mx mx mx mx
b. Setting goals and outcome criteria with the patient’s input
mx mx mx mx jc mx mx mx
c. Recording a drug history regarding over-the-counter medications used at home
jc mx mx mx mx mx mx jc mx
d. Formulating human needs statements regarding insufficient knowledge related to t mx mx mx mx mx mx mx jc mx
he new treatment regimen
mx mx mx jc
ANS: A mx
Education is an intervention that occurs during the implementation phase. Setting goals and
mx mx mx mx mx mx mx mx jc mx mx mx
outcomes reflects the planning phase. Recording a drug history reflects the assessment phase
mx jc jc mx mx mx mx mx jc mx mx mx jc
. Formulating human needs statements reflects analysis of data as part of planning.
mx mx mx mx mx mx mx mx mx mx mx mx
Chapter 1 -
mx mx 4
The Nursing Process and Drug Therapy
mx mx mx mx mx mx
